Engineered Alpha-Synuclein Mouse Models Reshape Parkinson’s Therapy Testing
A new review details how engineered alpha-synuclein mouse models with defined biochemical defects are transforming Parkinson's disease therapy development.
A new review details how engineered alpha-synuclein mouse models with defined biochemical defects are transforming Parkinson's disease therapy development.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine